Abstract: Methods and devices for diagnosing, monitoring, or determining diabetic nephropathy or an associated disorder in a mammal are described. In particular, methods and devices for diagnosing, monitoring, or determining diabetic nephropathy or an associated disorder using measured concentrations of a combination of three or more analytes in a test sample taken from the mammal are described.
Type:
Application
Filed:
March 8, 2021
Publication date:
July 22, 2021
Applicant:
MYRIAD RBM, INC.
Inventors:
Samuel T. LaBrie, James P. Mapes, Ralph L. McDade, Dominic Eisinger, Karri L. Ballard, Michael D. SPAIN